with metastatic melanotic peripheral nerve sheath sarcoma

with metastatic melanotic peripheral nerve sheath sarcoma prognosis Rare malignant melanotic nerve sheath tumors of the upper limb nerves: utility of Frontiers | Case Report: Anlotinib

Name: with metastatic melanotic peripheral nerve sheath sarcoma prognosis Rare malignant melanotic nerve sheath tumors of the upper limb nerves: utility of Frontiers | Case Report: Anlotinib
Brand: iglepidom.org
SKU: 42598184511
Price: 25.21 USD
Availability: InStock
Rating: 4.0729 (10 reviews)

Frontiers Case Report: Anlotinib combined with radiotherapy achieves sustained disease control in advanced malignant melanotic nerve sheath tumor Malignant Tumors of Peripheral Nerves Springer Nature Link Malignant Melanotic Nerve Sheath Tumor of the Neck: A Case Report Applied Radiation Oncology Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management PMC

SKU: 42598184511 · From iglepidom.org

4.1

USD25.21 USD65.21

Pay in 4 interest-free payments of $6.30 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 5 - Aug 10

Description

LLSH, but not LNSH, was associated with new/worsened sexual symptoms, including low desire [OR = 2.67 (1.275.60)], erectile dysfunction [OR = 4.53 (2.0510.01)] and infrequent morning erections [OR = 3.40 (1.487.84)]

To this extent, our present exploratory examination of the relation between baseline symptoms and treatment responsiveness suggests that variations in symptom presentation may influence how patients respond to these treatments